ArticleCureus2025
Unilateral Photopsia: An Unusual Case of Syphilitic Endophthalmitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Syphilitic endophthalmitis represents a rare ocular manifestation that can occur in both immunocompetent and immunocompromised patients. It is often misdiagnosed due to its resemblance to many other infectious, inflammatory, malignant, and rheumatologic conditions. This report describes the case of a 66-year-old male patient who presented with visualizing bright lights in the left eye associated with a significant decline in visual acuity. A series of investigations was done, including a temporal artery biopsy with unremarkable findings. Furthermore, vitreous aspiration was performed with Gram stain revealing trace gram-positive cocci with negative culture results. Intra-vitreal vancomycin and ceftazidime were given with no symptomatic improvements. On the other hand, the serum rapid plasma reagin (RPR) titer was 1:128 with positive syphilis serologies. The patient was started on penicillin-G 4 million units intravenously every four hours for two weeks, followed by benzyl-penicillin 2.4 million units intramuscularly weekly for three weeks. Significant improvement in visual acuity was noted after completion of antibiotic therapy, with routine retinal screening demonstrating resolution of hypopyon. This case illustrates the importance of screening for syphilis in patients with unexplained changes in visual acuity, as prompt identification of syphilis and initiation of treatment are associated with favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.